Search results
Mar 25, 2021 · The Bangladeshi company was founded in 1976. Four years later, Beximco Pharmaceuticals started manufacturing products under the licences of Germany-based Bayer and Upjohn of the US, and launched its own formulation brands three years later. In 1985, it was listed on the Dhaka Stock Exchange. Today, Beximco manufactures and markets its own ...
BLOOMBERG: BXPHAR:BD. damentalsBeximco Pharmaceuticals Limited (BXPHARMA) commenced its manufacturing operatio. in 1980. The Company is engaged in manufacturing and marketing of generic pharmaceuticals formulation products including life-saving intravenous fluids and Active Pharmaceuticals Ingredients (APIs) for both national and internation.
Aug 21, 2024 · Beximco Pharmaceuticals Limited: Forcasts, revenue, earnings, analysts expectations, ratios for Beximco Pharmaceuticals Limited Stock | BXP | US0885792061 b3d2254a71ed6f219193c687676a4.PMmwWNHdxrDD4sHhUnVBVLUo_BeDF3G9384I-DJ0Nsc.a7qECri4oty0s_ilIQ0oGcwYtmSzSCbUlaN_sEUrD5hLpcIhqayQ_qyvsg
- Local vs International Manufacturing
- Technology Transfer
- 1976 to The Present
- Environmental Concerns
Beximco's main manufacturing site is spread across a 22-acre area located near Dhaka, Bangladesh’s capital city. To build a better picture of the local manufacturing landscape Beximco works with, Reza explains that though companies in Bangladesh are producing large quantities of molecules, the actual number of products coming out of the country is ...
BEXIMCO BY THE NUMBERS: –15 million canisters of metered-dose inhalers per annum –36 million units of dry powder inhaler per annum –37 million units of liquid dosage per annum –6 million units of creams and ointments per annum –10 million units of suppositories per annum –5 billion tablets on a single shift It is interesting to consider the lack of...
Incorporated more than 40 years ago in 1976, the journey the company has taken is important to understanding how it got to where it is today. The pharmaceutical company operates within a larger organisation, but a Group is not a legal entity in Bangladesh. This means that the many branches of Beximco have little to do with one another, and mostly j...
One of the biggest future concerns for pharmaceutical companies across emerging and developed markets is sustainability; both financial and environmental. Commenting on Beximco's eco-friendly initiative, Reza says that the UN actually shows Beximco as an example in third world countries for how it cares for the environment. He talks about the compa...
For further information please visit www.beximco-pharma.com or enquire to: Beximco Pharma Nazmul Hassan MP, Managing Director Tel: +880 2 58611001, ext.20080 S M Rabbur Reza Chief Operating Officer Tel: +880 2 58611001, ext. 20111 SPARK Advisory Partners Limited (Nominated Adviser) Mark Brady / Andrew Emmott Tel: +44 (0)20 3368 3551 / 3555
Balance Sheet Beximco Pharmaceuticals Limited. Equities. BXPHARMA. BD0453BXPH04. Pharmaceuticals. End-of-day quote Dhaka S.E. Other stock markets. 2024-10-09. 5-day change.
People also ask
Does Beximco support foreign partners?
When was Beximco founded?
Who is Beximco?
Is Beximco a good company?
How many foreign employees does Beximco have?
Is Beximco a generic company?
Feb 2, 2015 · Beximco: A story of success. Feb 2, 2015 by m r. Beximco is the country’s largest group With $834 million in revenue, 45,000 employees and a market capitalization of $1.7 billion on the Dhaka Stock Exchange. It was born when the country was in the midst of a bloody battle for independence from Pakistan.
